Alexion Pharmaceuticals CEO Sells 54K Shares and 4 Insider Sales to Note

Bell Leonard who is CEO at Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), sold 54,548 shares at $105.25 per share for a total value of $5,740,924. The shares recently traded at $104.43, down $0.82, or 0.78% since the insider sale.

ALXN-20130820

Dehne Timothy R who is VP, Systems R&D at Luminex Corporation (NASDAQ:LMNX), sold 32,297 shares at $20.66 per share for a total value of $667,340. The shares recently traded at $20.74, up $0.08, or 0.39% since the insider sale.

ALXNN-20130820

Bassoul Selim A who is CEO, Chairman, President at Middleby Corp. (NASDAQ:MIDD), sold 11,295 shares at $190.09 per share for a total value of $2,147,067. The shares recently traded at $189.78, down $0.31, or 0.16% since the insider sale.

MIDD-20130820

Jeffs Roger who is President & COO at United Therapeutics Corp. (NASDAQ:UTHR), sold 10,000 shares at $71.21 per share for a total value of $712,100. The shares recently traded at $70.74, down $0.47, or 0.66% since the insider sale.

UTHR-20130820

Riccio Daniel J. who is Senior Vice President at Apple Inc. (NASDAQ:AAPL), sold 1,076 shares at $501.15 per share for a total value of $539,240. The shares recently traded at $507.74, up $6.59, or 1.31% since the insider sale.

APL-20130820

Don’t Miss: Will Apple Lose to This Major Patent-Licensing Company?

More Articles About:   ,  

More from The Cheat Sheet